Skip to Main Content

GR_3_24_23

March 24, 2023
ID
9733

Transcript

  • 00:00Donna and.
  • 00:04Thank you Donna.
  • 00:05Thanks to the Karasu lecture committee.
  • 00:08It's it's such a pleasure to be to
  • 00:10be back here to be back at Yale and
  • 00:12New Haven to see so many friends
  • 00:15and colleagues and I'm thrilled
  • 00:17that we're able to do this at least
  • 00:19hybrid with some people in person
  • 00:21because I mean after I'm going to be
  • 00:23talking about community approaches
  • 00:24to treatment and to do that in zoom
  • 00:27we've managed we've gotten by but
  • 00:29we've lost a lot and the the power of
  • 00:32people and the power of connections.
  • 00:35Because that is really what what
  • 00:37I want to focus on.
  • 00:39So I'm honored to give the
  • 00:42Carasau leadership lecture,
  • 00:44you know, among other things.
  • 00:47Professor Cara Sue is the cofounder and
  • 00:51long time director of the Leadership
  • 00:54Conference for the Tarrytown Leadership
  • 00:57Conference for cheap residents.
  • 01:00And so for over 50 years,
  • 01:02said Nikki established that in 1972.
  • 01:05For over 50 years,
  • 01:07they've been training chief
  • 01:08residents to be effective leaders.
  • 01:10They do it experientially.
  • 01:12They provide them training
  • 01:14around conflict resolution,
  • 01:15around strategic planning.
  • 01:17I want you to think about
  • 01:19the leveraged impact,
  • 01:21the multiplier effect.
  • 01:22Think about all the chief
  • 01:25residents he's trained,
  • 01:26they trained and then all the residents
  • 01:29they trained and all the now practicing
  • 01:31psychiatrists who were affected and
  • 01:34all the patients and communities.
  • 01:36So this enormous multiplier effect from,
  • 01:41you know,
  • 01:42from his intervention using social networks.
  • 01:45Ohh.
  • 01:47So when I started, let me.
  • 01:52I got it.
  • 01:53Yes, it's recorded,
  • 01:54so I don't have anything
  • 01:56to disclose and about.
  • 02:00That's my team now at Howard,
  • 02:03which is a huge group of people and
  • 02:05it's at both at Howard and across
  • 02:08a number of other institutions.
  • 02:10When I, when I started here at Yale,
  • 02:13I was very, very fortunate to,
  • 02:15you know, join an established,
  • 02:17small established group with her cleber,
  • 02:20Charlie Reardon,
  • 02:21rosalis programs and then to be
  • 02:24part of this initial amazing
  • 02:27cohort of Co faculty members.
  • 02:29Including Bruce Rounsville,
  • 02:32Tom Costin, Stephanie O'Malley,
  • 02:34you know,
  • 02:35Kathy Carroll and me and you know
  • 02:38then I think we have helped and you
  • 02:41know developed this program that
  • 02:43the more I see it's like who would
  • 02:46have imagined the ways that it would
  • 02:49flourish and the types of programs.
  • 02:50When I got to Howard,
  • 02:53I was also really fortunate to
  • 02:55be able to to be able to build
  • 02:58on previous work and so I.
  • 02:59I really didn't want to acknowledge
  • 03:02how those now, unfortunately,
  • 03:04the late Dean Robert Taylor,
  • 03:07who had been the chair of
  • 03:10the Pharmacology department,
  • 03:11had been the Dean of the College of Medicine.
  • 03:14Was a noted alcohol researcher,
  • 03:18established the Alcohol Research
  • 03:20Center at Howard, and it would,
  • 03:23you know,
  • 03:24focused on both genetics and increasing
  • 03:29diversity in biomedical research.
  • 03:31I was fortunate it was at
  • 03:33the end of his career.
  • 03:34I would have loved it had I gotten earlier,
  • 03:37but benefited from meeting him.
  • 03:39And then that team that I showed you,
  • 03:41core members of it were people.
  • 03:43He said, well, you ought to take over.
  • 03:45The work that we've been doing,
  • 03:46I have this great team and indeed he did,
  • 03:48so we've benefited from that.
  • 03:53OK, so here's what I want to
  • 03:54talk about this morning. So.
  • 03:57And it's the specific problem,
  • 03:59but it's clearly embedded in larger ones.
  • 04:02So opioid overdose death
  • 04:03rates are skyrocketing,
  • 04:05continuing to skyrocket in the United States.
  • 04:08One of the four pillars of for reducing
  • 04:11the deaths is to engage and retain
  • 04:14persons with opiate use disorder
  • 04:17and medication treatments. MUD.
  • 04:20We've increased overall utilization of MUD.
  • 04:25We certainly increased
  • 04:27availability to it nationally,
  • 04:30but still less than 25% of the people
  • 04:33who need it receive it in a given year.
  • 04:37And we should compare that to other places.
  • 04:39You know,
  • 04:40what's the benchmark is it's at least 50
  • 04:42or 60% in many European Union countries
  • 04:45and it's higher than that in some of them.
  • 04:48And then that problem underutilization
  • 04:51is particularly severe for African
  • 04:55American and American Indian
  • 04:57Native American communities.
  • 05:00And so we want to what address,
  • 05:02what accounts for the disparities and what
  • 05:05can we do to address the treatment gap?
  • 05:08And then in urban
  • 05:11African-American communities.
  • 05:12So this is what I'll do.
  • 05:14I'll first go briefly through
  • 05:16the four waves of the opiate of
  • 05:19the overdose epidemic nationally.
  • 05:22We'll talk about the changing demographics
  • 05:25and then that persistent treatment
  • 05:27gap and some of the efforts that have
  • 05:30been made to expand availability.
  • 05:32In a way you know Don alluded to
  • 05:34some of the things we had done here
  • 05:36to make treatment more available.
  • 05:38And then I want to do a deep dive
  • 05:40focus on what we've been doing
  • 05:42on the District of Columbia.
  • 05:43And what we've been doing there
  • 05:46to address the problems including
  • 05:48building community collaborations,
  • 05:50qualitative research to gain a deeper
  • 05:53understanding of the barriers and
  • 05:55facilitators for engaging people
  • 05:57in treatment and then developing
  • 06:00and implementing a multi pronged
  • 06:02strategy in partnership with Community
  • 06:05resources to overcome the barriers,
  • 06:08increase engagement and retention and
  • 06:10treatment and support a healthy community.
  • 06:16OK. So here this slide shows the four
  • 06:19what we now think of as four waves
  • 06:21of the opioid overdose epidemic.
  • 06:23And you know what we see is
  • 06:27that beginning in about 2000,
  • 06:30there's this the black line
  • 06:31up top is any opioid deaths.
  • 06:33But what drove the epidemic during the
  • 06:36first wave was prescription opioids,
  • 06:38oxycodone and other prescription
  • 06:42opioids beginning in about 2010, 2011.
  • 06:47Began to see a spike in heroin related
  • 06:51overdoses that then continued to increase.
  • 06:54We were at that point decreasing the
  • 06:57amount of prescription opioids out there.
  • 06:59We were engaging in some primary prevention,
  • 07:02better prescribing other
  • 07:03parts of the pillars.
  • 07:05But now heroin started causing a
  • 07:09spike or continued overall growth
  • 07:12and then beginning in the 2013,
  • 07:162014 terrible introduction
  • 07:18of synthetic opioids,
  • 07:19fentanyl, car fentanyl,
  • 07:21other synthetic opioids causing
  • 07:24this enormous spike that's continued
  • 07:26and then the 4th wave was the
  • 07:30Co occurrence of stimulants,
  • 07:32methamphetamine and cocaine.
  • 07:33Contributing to this 4th wave
  • 07:36of the epidemic.
  • 07:39Along with that shift.
  • 07:41In here to heroin and then synthetic
  • 07:45opioids has been a shift in the geography.
  • 07:49So whereas the prescription
  • 07:51opioids hit first part because
  • 07:53they were marketed to rural areas,
  • 07:56out hit first and rural communities.
  • 08:00The epidemic overdoses have increased,
  • 08:03have gone increasingly rising increasingly
  • 08:06fast in big cities and urban cities.
  • 08:10And so, so we see this is the most recent,
  • 08:14yeah, pointers up there.
  • 08:16This is the most recent statistics and it
  • 08:18looks at the opiate overdose death rates.
  • 08:21That's Baltimore.
  • 08:22That's the national average.
  • 08:24And here's a series of other cities.
  • 08:27Virtually all the big cities
  • 08:28far exceed the national average.
  • 08:30And overdose death rates.
  • 08:33And this looks at different
  • 08:36ethnic rich groups.
  • 08:38You know what the difference is?
  • 08:40Rural, urban, and in most groups
  • 08:44they're comparable relatively.
  • 08:46It's always higher now in urban.
  • 08:48Except among non Hispanic,
  • 08:50Hispanic,
  • 08:51black people where the stark
  • 08:53differences if you're non Hispanic
  • 08:56black person living in an urban area,
  • 08:59you're more than twice as likely
  • 09:01to die of an overdose at twice
  • 09:03the rate of overdose deaths.
  • 09:05So this epidemic has moved
  • 09:07from rural to urban.
  • 09:12And it's also changed in terms of
  • 09:15the complexion of who's dying of
  • 09:18opiate overdose deaths. So the early.
  • 09:23This is the beginning.
  • 09:25And these are whites and OHS and
  • 09:29American Indian or Alaska natives.
  • 09:33Which has been a hidden population?
  • 09:35Or hidden in the sense not hidden
  • 09:36to people who are experiencing it,
  • 09:38but hidden in the press, right?
  • 09:40Who it or know that now that the
  • 09:43overdose death rate has exceeded
  • 09:45the entire time and grown at a
  • 09:47faster rate American Indians,
  • 09:49Native Americans than in whites?
  • 09:52But beginning with the introduction of,
  • 09:55you know, the heroin and then the
  • 09:58synthetic opioids and most recently.
  • 10:02It was Co occurring stimulants.
  • 10:05The overdose death rate among black persons.
  • 10:11Is African Americans has far
  • 10:14outpaced that among whites,
  • 10:17and the death rate now exceeds
  • 10:18the death rates for whites.
  • 10:20This is not a race that anybody wants to win.
  • 10:25And what that means for the District
  • 10:28of Columbia. Is this by 2021,
  • 10:30this looks at overdose death rates,
  • 10:33age adjusted per 100,000 persons and
  • 10:36DC and the district is classified as a
  • 10:40state by CDC and that's their CDC data.
  • 10:44So Washington DC now leads every
  • 10:48other jurisdiction in the country.
  • 10:50And overdose death rates closely
  • 10:52followed by West Virginia,
  • 10:54which had been traditional epicenter.
  • 10:57And then here are the rates.
  • 10:59Elsewhere.
  • 11:02And now let's look a little bit more
  • 11:04closely at the district what's happening
  • 11:06in the in the District of Columbia.
  • 11:08So and and and here we just see
  • 11:12this exponential growth you know
  • 11:14rate the growth in overdose deaths.
  • 11:17Basically tripled from 2014 to 2016,
  • 11:21nearly doubled from 2016 to 2020,
  • 11:24and it's grown substantially more since then.
  • 11:28And this graph here shows overall number of
  • 11:33opiate overdose deaths by year 2016 to 2020.
  • 11:38It also begins to show the contributions
  • 11:41of different of the different drugs and
  • 11:45increasingly fentanyl has been the.
  • 11:47You know, found that it's about
  • 11:49now what 90% of the deaths are
  • 11:52are related to synthetic opioids.
  • 11:55But the second part is that the overdose
  • 11:58deaths and the increase in overdose
  • 12:00deaths occur almost entirely among black
  • 12:03people and mainly older black males.
  • 12:0785% of the overdose deaths in Washington,
  • 12:11DC occur among black people.
  • 12:14And about 3/4 of the deaths occur
  • 12:19if 3/4 of those are among black men.
  • 12:23So, so the death is highly concentrated
  • 12:26out and they're older black males,
  • 12:29although that is unfortunately
  • 12:30also shifting so that we're seeing
  • 12:32more and more younger people,
  • 12:34but we'll tell you more and it's
  • 12:36highly concentrated in this last
  • 12:37graph looks at death rates by Ward and
  • 12:39I'll show you for those who don't,
  • 12:41I didn't know if the district
  • 12:43wards until I got down there.
  • 12:44But the death rates are highest
  • 12:47in Ward seven and eight,
  • 12:49and neighboring areas and Wards 5 and six.
  • 12:55So where awards seven and
  • 12:56eight and five and six.
  • 13:018765.
  • 13:04The White House, downtown DC,
  • 13:08the red line, ohh,
  • 13:11you know the people know the so, so there.
  • 13:15And then this is the Anacostia River.
  • 13:18So it's basically east of the Anacostia
  • 13:21River and the area right across from it
  • 13:25and what we look at in those wards and
  • 13:27I'll show you just a couple of them,
  • 13:29any health disparity statistics.
  • 13:33They're the hardest hit,
  • 13:34so this is infant mortality rates.
  • 13:36Could be more maternal mortality rates.
  • 13:39It's the same thing.
  • 13:40The highest by far, you know,
  • 13:4311 to 14 or 15 per thousand live births.
  • 13:46That's just about as bad as
  • 13:49the worst places in the world.
  • 13:51It's not the worst in the world,
  • 13:53but it's certainly out.
  • 13:55It's not at all what you'd expect.
  • 13:57It's not what you see in
  • 13:58the rest of the district.
  • 14:03Worth 7 and eight and those areas in five
  • 14:07and six remain the most racially segregated.
  • 14:10Looks at proportion of the Population
  • 14:12board seven and eight or 90% or more.
  • 14:17African American have the highest
  • 14:20unemployment, highest poverty.
  • 14:21Most people living below you know,
  • 14:25poverty line have the least health resources.
  • 14:29These are clusters of all the
  • 14:32various clinics and hospitals.
  • 14:33There's now no hospital,
  • 14:35General Hospital in Ward 7 or 8.
  • 14:38There's no transportation
  • 14:39to get out of there,
  • 14:40and public transportation is terrible.
  • 14:42These are food deserts.
  • 14:44So these are really neglected areas
  • 14:47that have been historically neglected.
  • 14:53So the opiate fatality review board,
  • 14:58out of office of the Chief Medical Examiner
  • 15:01we've been looking at and who are the
  • 15:05who's dying of the opiate overdose deaths?
  • 15:07And here are some of the
  • 15:09additional characteristics.
  • 15:10At least up until a couple of years ago,
  • 15:12which is the most recent stats
  • 15:14that we've pulled together,
  • 15:16about 88% produced heroin
  • 15:18for more than 10 years.
  • 15:21Nearly 60% had using for 25 years.
  • 15:2522% had been using heroin
  • 15:27for more than 40 years.
  • 15:29Despite that incredibly long period of use,
  • 15:33less than 20% had ever received
  • 15:36any substance use treatment.
  • 15:38From the records and these are estimates.
  • 15:39We may have missed something.
  • 15:41And as best we could tell,
  • 15:42only about 10% had ever
  • 15:44received medication treatment.
  • 15:48So this pattern of underutilization
  • 15:51of medication treatment. Is.
  • 15:54Particularly stark for black or
  • 15:58other minoritized populations.
  • 16:01And now we'll do talk a little bit
  • 16:03more about that. We know that.
  • 16:06As of 22,019 was really the most
  • 16:11recent data we can look at.
  • 16:14Only about 17% of the 2.2 million people
  • 16:18with past year opiate use disorder.
  • 16:21Receive medication treatments
  • 16:23for opiate use disorder.
  • 16:25There's an additional set of people who
  • 16:28are on medication treatment not using.
  • 16:29They don't meet criteria any longer so
  • 16:33that but 17% of people past year and
  • 16:36that's much worse for black persons.
  • 16:38You could look at it any number of ways here,
  • 16:40just a couple of the key findings
  • 16:43if you look at in Massachusetts.
  • 16:45Pregnant women.
  • 16:46They're all covered by one form of
  • 16:48insurance or another, and a black,
  • 16:51non Hispanic pregnant woman with
  • 16:53opiate use disorder 30% less
  • 16:55likely than her counterpart,
  • 16:57White pregnant woman to receive
  • 17:00medication treatment during pregnancy
  • 17:02following an opiate overdose
  • 17:04treated in an emergency room.
  • 17:06Black patients are about half as likely
  • 17:08as whites to receive medication treatment.
  • 17:11Across primary healthcare systems,
  • 17:13it's the same finding even in
  • 17:16this the national based on the
  • 17:18national Survey on Drug use,
  • 17:20it's about a third black patients.
  • 17:22But black people with opiate
  • 17:24use disorder past year,
  • 17:25about 1/3, is less likely to to
  • 17:30receive medication treatment.
  • 17:32In addition to that,
  • 17:33when you look at retention,
  • 17:34I'm not going to show you a slide.
  • 17:36Retention is much lower for black
  • 17:38persons with opiate use disorder.
  • 17:40When they do enter treatment,
  • 17:41they leave faster.
  • 17:42And in the past several years,
  • 17:45we've made gains nationally in the
  • 17:47number and percentage of white people,
  • 17:49patients who are staying on treatment
  • 17:51for long enough period of time,
  • 17:54you know, 180 days.
  • 17:55It's gone in the other direction for
  • 17:59black persons with opiate use disorder.
  • 18:02Now we've done a lot here and I don't
  • 18:04want to talk about all the efforts,
  • 18:06but you know they're bringing
  • 18:08medication treatments into primary
  • 18:10care and office space settings,
  • 18:12introducing it into emergency department
  • 18:16initiated treatments or you know,
  • 18:20developing Open Access clinics,
  • 18:22being able to bring people in rapidly.
  • 18:25We've expanded.
  • 18:27MUD availability,
  • 18:29so predominantly through office space.
  • 18:32Buprenorphine these are.
  • 18:34It's an older slide, but this is methadone.
  • 18:37Methadone has remained pretty
  • 18:39stagnant for a variety of reasons.
  • 18:42But who's benefited?
  • 18:44So up until about 2015, all the increased.
  • 18:50Utilization essentially of buprenorphine.
  • 18:53Was among white persons with
  • 18:56opiate use disorder.
  • 18:57And this is part of the reason,
  • 18:59but it's, you know,
  • 19:01it's just the one sign this is,
  • 19:03I just pulled this off a few years back,
  • 19:05the Internet.
  • 19:06Pictures that were coming from
  • 19:09advertisements from buprenorphine,
  • 19:11buprenorphine clinics and buprenorphine
  • 19:14manufacturers and the faces of
  • 19:17the national advocacy groups.
  • 19:20And I actually at that point did not see,
  • 19:24couldn't find a single black person
  • 19:28medication treatment now being shown.
  • 19:32That's a little better now.
  • 19:35OK,
  • 19:36so I'm going to spend the remainder
  • 19:38of the
  • 19:39talk as promised talking about.
  • 19:41What's happening in the district
  • 19:42and what we've been doing there to
  • 19:45to try to address this problem.
  • 19:46So, so in the district in a good way,
  • 19:49we've addressed the district some before I
  • 19:52got there and some over the past few years.
  • 19:55Many of the structural barriers,
  • 19:57so the district expanded
  • 19:59Medicaid and then for the.
  • 20:0310% predominantly.
  • 20:06That next Hispanic immigrants
  • 20:07out who aren't eligible even for
  • 20:10Medicaid or commercial insurance.
  • 20:12The district provides free buprenorphine
  • 20:15treatment through a drug assistance program.
  • 20:19Eliminated copays and the requirements
  • 20:22for pre authorization requirements.
  • 20:24We've done a huge amount of
  • 20:26training now the waivers gone,
  • 20:28but we trained a large number
  • 20:29of people to be waived.
  • 20:31You know be able to prescribe buprenorphine
  • 20:33many of them were we're doing it,
  • 20:35ready to do it,
  • 20:37interested in doing it.
  • 20:38Every single federally qualified
  • 20:40Health Center provides buprenorphine
  • 20:43treatments out and we've initiated
  • 20:46emergency department initiated.
  • 20:49Medication treatment in every
  • 20:52hospital emergency department.
  • 20:54Despite that,
  • 20:55the district ranks 32nd in the nation
  • 20:58buprenorphine prescribing rates
  • 20:59and is one way of looking at it.
  • 21:02With that expansion of Medicaid
  • 21:04between 2016 and 2018,
  • 21:06treatment capacity just based
  • 21:09on the number of buprenorphine
  • 21:12providers increased by 5500 patients.
  • 21:15But there are only 132 more patients
  • 21:19on Medicaid receiving buprenorphine
  • 21:22treatment in 2018 than in 2016.
  • 21:25And the clinics like one of our partner
  • 21:29FQHC's, had about 100 out of they.
  • 21:33They figured they could treat
  • 21:35at least 600 patients.
  • 21:37So so why aren't?
  • 21:39Patients who aren't people with
  • 21:41opiate use disorder coming for it.
  • 21:49This. You know, I used to think this
  • 21:51humbled me because I used to think
  • 21:52if we build it, they will come.
  • 21:54Alright, the guy had slides about it.
  • 21:57That was, you know, the question if we
  • 21:58just build the capacity, people will come.
  • 22:00And to some extent it was true, but here
  • 22:03we hit the limits of where it's not true.
  • 22:06So when I first got there or,
  • 22:08you know, because I was brand new,
  • 22:10I needed to learn, I needed to meet people.
  • 22:11And so I started my own,
  • 22:14learned this thing here, Connecticut
  • 22:16Mental Health Center and, you know,
  • 22:18the community coalitions and how do you,
  • 22:21you know, get in the app foundation.
  • 22:23So we met with community leaders,
  • 22:26including faith leaders, health centers,
  • 22:29other service providers,
  • 22:30sort of attending community forums and then
  • 22:34we assembled from Ward seven and eight.
  • 22:36A Community Advisory Board
  • 22:38and this has been an amazing,
  • 22:40fabulous group of people.
  • 22:42A pastor of a large church,
  • 22:44director of the faith-based Community Center.
  • 22:47And advisory Neighborhood Health Council
  • 22:50director, community outreach workers.
  • 22:52Peers in recovery.
  • 22:55And started meeting regularly with
  • 22:57them to say how are we going to
  • 23:01address this problem and and they
  • 23:03have Co lead the research and program
  • 23:07development from the from the very start.
  • 23:12And I think I was a little impatient
  • 23:14internally when I started because
  • 23:16I was ready to do something.
  • 23:17But this is a problem.
  • 23:18We got to do something and they said
  • 23:21we need to understand it and and
  • 23:23I have grown to absolutely trust
  • 23:26this process because.
  • 23:28We're doing better than we would have.
  • 23:29We would have failed terribly
  • 23:32and they've had great ideas.
  • 23:34So immediately just with the cab with
  • 23:36our Advisory Board started telling
  • 23:38us remember I I started being able to
  • 23:41do this because I got one of these
  • 23:43heel initiative grants on opiates and
  • 23:45I told them what we were going to
  • 23:48do on opiates and it had to focus on
  • 23:51opiate use disorders in this you know,
  • 23:54hard hit area.
  • 23:55And the first thing they said is look.
  • 23:57Communities have strong,
  • 23:59deep roots and strengths.
  • 24:01Don't come in here and just focus
  • 24:03on our problems.
  • 24:04Come in here and figure out what
  • 24:06our strengths are and build on
  • 24:09them and strengthen the community.
  • 24:10Second was don't come in here
  • 24:13and just focus on opiates.
  • 24:15And we don't trust you or you know,
  • 24:18what's this sudden shift?
  • 24:20Why now is there the sudden interest
  • 24:23in opiates and a shift to view the
  • 24:26problems of medical and not criminal?
  • 24:27We've been going to jail for years for
  • 24:30drug problems and now people want to
  • 24:32come in and a public health effort.
  • 24:34Why now only when white people are
  • 24:36dying of overdoses, this change happened.
  • 24:38To the people in charge of the funding
  • 24:41and policies and priorities do the
  • 24:44researchers or treatment providers need?
  • 24:46Really care about us.
  • 24:50Those are.
  • 24:51Themes and questions that resonate deeply,
  • 24:55as we'll see from interviews
  • 24:58and focus groups
  • 25:00that we did. So this don't focus
  • 25:02on treatment and recovery only and
  • 25:04don't certainly don't focus on or
  • 25:06focus on treatment and recovery,
  • 25:08don't focus on medications. Yeah.
  • 25:11My view was we can get people to take
  • 25:13the medications will save a lot of lives.
  • 25:15I still think that.
  • 25:16But people aren't interested
  • 25:18just in the medications.
  • 25:20And that's just another way for
  • 25:22pharmaceutical companies to make
  • 25:23money off of us again, that.
  • 25:25Deep mistrust.
  • 25:26Distrust of the medical system is part of,
  • 25:31you know, the roots of the problem,
  • 25:33and we'll see more from the
  • 25:35interviews around it.
  • 25:36And then focus on drug addiction generally,
  • 25:39not just on opioids.
  • 25:41And don't focus only on drugs.
  • 25:44This problem doesn't occur in isolation.
  • 25:47The disparities economic and housing
  • 25:50problems, insecurity, transportation,
  • 25:52limited healthcare services,
  • 25:54trauma.
  • 25:54And I personally struggled with
  • 25:56this because I don't have any
  • 25:58expertise in many of those.
  • 26:00And what they challenge me said,
  • 26:01OK, you bring your expertise,
  • 26:02but join us in the larger struggle.
  • 26:05And play with the expertise,
  • 26:07but don't think that that's
  • 26:09going to be alone enough.
  • 26:10And so we need allies and we need,
  • 26:13you know,
  • 26:13we need you to be thinking about it.
  • 26:15And then they set out and created about
  • 26:18a really powerful vision statement.
  • 26:20Ward seven and eight to be healthy,
  • 26:23thriving communities where residents
  • 26:25experience freedom from problems
  • 26:27with substance use and addiction.
  • 26:30And a mission you know we're
  • 26:32to increase access to effective
  • 26:34recovery and treatment services,
  • 26:36reduce stigma and deal with the
  • 26:38root causes of unhealthy drug use.
  • 26:41They also came up with this fabulous
  • 26:44logo that connects the wards and
  • 26:47the district in this puzzle and
  • 26:50and the Better Together name
  • 26:51that wasn't where we started.
  • 26:55And the first thing they
  • 26:57challenged us to do and suggested,
  • 26:59which got some medical students
  • 27:01and residents, that was created.
  • 27:02Community asset map. What's here?
  • 27:04What's in the community?
  • 27:06And and then.
  • 27:08Two of our medical students
  • 27:10and Morgan Medlock,
  • 27:12who's been on our faculty developed
  • 27:15some geospatial modeling when looking
  • 27:18at assets over overdoses with a view.
  • 27:21Eventually, you know as we got into a closer
  • 27:24view of where overdoses were occurring,
  • 27:26you might be thinking about where
  • 27:29the really local resources that we
  • 27:32might tie into to address hotspots.
  • 27:35And then get more input.
  • 27:39And this is where I'll spend sort of the
  • 27:41bulk of the remainder of the time talking
  • 27:44about the interviews and focus groups
  • 27:46that we've done with community leaders,
  • 27:49advocates, outreach workers,
  • 27:51healthcare workers,
  • 27:52persons with lived experience or in recovery
  • 27:57or currently using and family members.
  • 28:00And now we sort of created these artificial
  • 28:03buckets and that's how we recruited people,
  • 28:06but of course.
  • 28:08Community leaders, healthcare workers
  • 28:09have a lot of lived experience,
  • 28:11so to some of the family members,
  • 28:13so there's people speak with
  • 28:16multiple hats and identities,
  • 28:18but those are the buckets
  • 28:20that we recruited them in.
  • 28:22We worked with the CAB to develop an
  • 28:26interview guide community how opioids,
  • 28:28other substances affect the community.
  • 28:32Power of people view people
  • 28:33don't be used disorder.
  • 28:35How do they view treatments,
  • 28:36including medication treatments?
  • 28:37What makes it harder or easier
  • 28:40for people to get treatment?
  • 28:42What could make it better?
  • 28:45We enter,
  • 28:45we did the audio tapes and transcribed
  • 28:49all the interviews and then.
  • 28:51First time in my life I've been
  • 28:54really learning qualitative
  • 28:55research methods much more used to
  • 28:58randomized clinical trials and.
  • 29:00The data analysis is easier on the RCT,
  • 29:04but so we've developed codebooks,
  • 29:07I'm immersed in the transcripts
  • 29:10it's thinking about and and we've
  • 29:12been moving from rapid coding to
  • 29:15try to come up with plans quickly
  • 29:17and then formal coding so we
  • 29:20can be able to publish it.
  • 29:22So across the interviewee
  • 29:26participant categories.
  • 29:28Really identified 5 main themes identified,
  • 29:32you know,
  • 29:33some not surprising but powerful
  • 29:34and how they played out.
  • 29:36Stigmatizing views about persons with
  • 29:39opiate use disorder are prevalent.
  • 29:41Even among many community
  • 29:43leaders and health care workers.
  • 29:45And they keep people away from treatment.
  • 29:49There's incredibly powerfully strong
  • 29:52negative views about medication treatments.
  • 29:56And I was surprised by this because
  • 29:57I knew there were some here that I
  • 29:59didn't think we had that I don't
  • 30:01know if we did these interviews
  • 30:02what it would be like.
  • 30:04New Haven,
  • 30:05but I thought we had done a better
  • 30:07job talking about what it was
  • 30:09like and a corollary of that,
  • 30:11that the only real treatments are
  • 30:1312 step and abstinence base and
  • 30:16long term residential treatments.
  • 30:19And then a sad aspect was a
  • 30:22real sense of nihilism.
  • 30:24Nothing can be done.
  • 30:27I don't know how to intervene.
  • 30:28Nothing can be done successfully
  • 30:30to get anyone into treatment or
  • 30:33to help them remain in treatment.
  • 30:35And the last was what I think of as the
  • 30:38importance of social networks, peers,
  • 30:41trusted, credible messengers and getting
  • 30:44messages out and people into treatment.
  • 30:47So I'll give some snippets
  • 30:49of the transcripts.
  • 30:51What people were saying.
  • 30:53So stigmatizing views.
  • 30:54There was a medical provider.
  • 30:57Ohh. And the general question,
  • 31:00how would you describe the community?
  • 31:02Entitled. They just kind of want.
  • 31:06What they want, when they want. Ohh,
  • 31:10my research assistance was talking to them,
  • 31:13you know, as they've read some of
  • 31:16these comments they say. If I knew.
  • 31:19The people felt that way about me.
  • 31:21I wouldn't go and it's horrible.
  • 31:24Medical assistant is a different one,
  • 31:26describing patients with opiate use disorder.
  • 31:29They're sneaky.
  • 31:30They play with the system,
  • 31:31the system, the Suboxone system.
  • 31:34I'm pretty sure all of us feel like this.
  • 31:36Why are you in this program?
  • 31:37You should.
  • 31:37You should act as if you're not going to.
  • 31:39You're not going to take
  • 31:41this program serious.
  • 31:42Then you should get out.
  • 31:44Another medical provider and
  • 31:45we're really tell you the truth,
  • 31:48I still don't trust them.
  • 31:50I feel like there's too much
  • 31:51potential dangers for having
  • 31:52this prescription in their hand,
  • 31:54and I don't want any questions
  • 31:56with my name on that prescription.
  • 31:58A community leader, I mean,
  • 32:00they act like zombies.
  • 32:02Lack of motivation. It's just an eyesore.
  • 32:05It's something that those who don't
  • 32:07use drugs, we don't want to see it.
  • 32:09And.
  • 32:10We could spend, you know,
  • 32:12a long time reading other statements.
  • 32:14These are very, very prevalent views.
  • 32:18And we also heard the impact.
  • 32:21You know what's it like when you're
  • 32:23on the receiving end of that?
  • 32:25So there was a person who lived
  • 32:27experiences doing PR outreach.
  • 32:29But if you're always putting them down,
  • 32:30they're going to feel like,
  • 32:32hey, this is all I'm worth well,
  • 32:33and I'm going to do go and get high.
  • 32:37Or another person,
  • 32:38a community leader now have lived experience.
  • 32:41I got treated real bad and methadone clinic,
  • 32:45they put me down,
  • 32:46made me feel bad about myself,
  • 32:48told me I wasn't going to be one,
  • 32:49I was going to be one of the ones
  • 32:51who wasn't going to make it.
  • 32:52There was a couple of staff like that.
  • 32:54Not just one,
  • 32:54you know Park as I was so angry
  • 32:56because I got there and then noted.
  • 32:58But there was a counselor who believed in me,
  • 33:01motivated me, helped me stay clean.
  • 33:06And that had a big impact.
  • 33:07And then later in the interview
  • 33:10this person down doing community
  • 33:12leader who was working with one of
  • 33:15her people came to her agency to
  • 33:17try to help her get some housing
  • 33:20assistance and she describing it.
  • 33:21She said, well,
  • 33:22a lot of times people be embarrassed
  • 33:25about being in a situation.
  • 33:27You'd be so afraid that people
  • 33:28are going to judge you.
  • 33:30And the way that Lady talked to her,
  • 33:32so she was hearing the other,
  • 33:34you know,
  • 33:35the person on the other end of the
  • 33:37phone, the way that Lady talked to her,
  • 33:39it discouraged her.
  • 33:41Community leader who's a teacher will
  • 33:43get some other quotes from her and
  • 33:45a little bit on some other issues.
  • 33:47If it's their child,
  • 33:48their cousin or whatever,
  • 33:50they want them to get help,
  • 33:51but they also don't want anybody to see it
  • 33:53because there's stigma attached to it, like,
  • 33:55Oh my God, the child was a drug problem.
  • 33:59And then, of course, there's, you know,
  • 34:01the stigmatizing attitudes push people out.
  • 34:04But there's also a clear sense that.
  • 34:07Ohd. If you've got somebody
  • 34:10who's positive and receptive,
  • 34:12that's what welcomes you.
  • 34:13And so my doctor had a positive impact on me.
  • 34:16His impact, I think, was the greatest of all.
  • 34:20And people, they don't want to
  • 34:21come into a place where people.
  • 34:24See, they're not in recovery.
  • 34:25This is another the stigma.
  • 34:26They're afraid of being rejected,
  • 34:29looking weak.
  • 34:32So, so here's now just some
  • 34:34of the what we heard about.
  • 34:37How people see medication treatments.
  • 34:42Person with lived experience.
  • 34:43All you're doing is 1 drug
  • 34:45and going to another drug.
  • 34:47That's all. But nothing,
  • 34:48nothing stopping you from wanting heroin.
  • 34:51So once you start taking the methadone,
  • 34:52you have to drink it every day.
  • 34:54It's basically it's another drug.
  • 34:56Another person who lived experience
  • 34:58methadone is heroin and another form.
  • 35:01It's addictive. It hurts your body.
  • 35:02It's a little worse than heroin too,
  • 35:04in terms of your bone structures.
  • 35:06Here's your bones down and then it starts up.
  • 35:09I think Suboxone works because don't
  • 35:13have the addictive effects to it.
  • 35:15But most of the people sell Suboxone too.
  • 35:17You can sell a shot.
  • 35:20I know both sides,
  • 35:21so one side is saying it's not addictive,
  • 35:23but the other people use it for getting high.
  • 35:29More about from another community leader.
  • 35:32These are the people who want to
  • 35:33be the I want to be the advocates.
  • 35:35And they went on methadone.
  • 35:38Some of them can never get off the methadone.
  • 35:40Their bones cannot function.
  • 35:41Their bodies blew up, they become dead.
  • 35:44They're not productive in society.
  • 35:46I don't agree with you using
  • 35:48a drug to get people off.
  • 35:50And another community leader.
  • 35:52I've seen methadone as a way
  • 35:54of legally maintaining it.
  • 35:55It's almost like how you treat animals,
  • 35:58getting medication as a crutch in a way
  • 36:00that prevents us from realizing it,
  • 36:01tapping into that strength as a people.
  • 36:05So we heard that in the medical clinics too,
  • 36:09who've been clinics.
  • 36:11That are providing medication treatment.
  • 36:13So there there are some strong advocates,
  • 36:15but there are also a lot of people that
  • 36:18patients can come in contact with like.
  • 36:20Nurse like with methadone,
  • 36:21you trade 1 high for the next.
  • 36:24Now they hooked on methadone.
  • 36:25What you want them to do is to live a
  • 36:27normal life, not addicted to anything.
  • 36:30Another medical assistant.
  • 36:31Sometimes patients, they'll just get it.
  • 36:34So just to sell it.
  • 36:37It said not much we can do about that.
  • 36:41Family members echo.
  • 36:43Over from people, you know the same thing.
  • 36:47It's the same thing. People chase it.
  • 36:50Gets you high, messes your teeth up.
  • 36:52The teeth and the bones is.
  • 36:55Powerful.
  • 36:56In some ways it's more dangerous
  • 36:58because people look at it as if it's
  • 37:00not the same thing and there's a.
  • 37:02Person with her own lived experience
  • 37:04is one of the lead family describes
  • 37:07herself one of the lead family mental
  • 37:09health people in the community.
  • 37:11I have a problem with methadone.
  • 37:13I have a problem with harm reduction
  • 37:15in order folks to recover the
  • 37:17need to be abstinent.
  • 37:19Yeah,
  • 37:19they shouldn't be continuing to do drugs.
  • 37:24This is how one aspect of this is the
  • 37:27medical mistrust or distrust of medicine.
  • 37:30We had heard that from the from
  • 37:32our Community Advisory Board.
  • 37:33But then. Heard it over and
  • 37:36over again from the interviews.
  • 37:41You know, giving one drug for another,
  • 37:43it's more of a political thing with
  • 37:45this money and pharmaceutical and
  • 37:47some agencies that know they can make
  • 37:49money off methadone or suboxone.
  • 37:52It's more harmful than good, but I get it.
  • 37:54People want to make money.
  • 37:55It's all about the money.
  • 37:58Ohh somebody called it the treatment
  • 38:01industrial complex so it was
  • 38:04worried about making it easier to
  • 38:07get access to it from any doctor.
  • 38:10Doctor's abuse.
  • 38:11Their right to describe it, I think
  • 38:13they have used the medical treatment program.
  • 38:16And people who are just skeptical
  • 38:18with all sorts of medications.
  • 38:20Not too big on it.
  • 38:21People always go to that first,
  • 38:23like they just want to throw it at
  • 38:25somebody instead of talking to them.
  • 38:27Trying to understand anything.
  • 38:28And of course this is this level
  • 38:31of medical mistrust we all saw
  • 38:34around COVID vaccinations and,
  • 38:35you know, how difficult it was in
  • 38:39some communities to be able to get,
  • 38:41you know, high vaccination rates.
  • 38:49Part of the problem was what they
  • 38:52had seen with methadone programs.
  • 38:55There are only three in the district,
  • 38:57highly concentrated.
  • 38:58They're highly stigmatized,
  • 39:00they're large out and people passing by.
  • 39:06Don't see the successes?
  • 39:08Of methadone treatment,
  • 39:09they see the people who are hanging
  • 39:11out all day and so they gives this view
  • 39:14and we heard over and over you know,
  • 39:17what they people had seen and what
  • 39:19they don't want in their community.
  • 39:22You know, I think medication
  • 39:23treatment is a good thing,
  • 39:24but I think people abuse it.
  • 39:26They spit it back out and then sell it.
  • 39:28They get high.
  • 39:29All kinds of stuff is going on over there.
  • 39:32You get them all over the place,
  • 39:34nodding, making drug transactions.
  • 39:36It's a mess.
  • 39:37You see 30-40 people standing around.
  • 39:40They're just always busy
  • 39:41because they want that high.
  • 39:42That teacher and I'll talk
  • 39:44about her one more time,
  • 39:45but mention when she talked about
  • 39:47a methadone clinic that she passes
  • 39:49on her way to work and all these.
  • 39:52People here, people are high.
  • 39:53They're clearly on something.
  • 39:55And I'm like, Oh my God,
  • 39:57I don't want that in my community.
  • 39:59But how do we fix the people?
  • 40:01It doesn't seem good that you have
  • 40:03a whole group of people addicted to
  • 40:06something in the same place at the same time,
  • 40:08because it's nothing good bound to happen.
  • 40:10It's a recipe for disaster.
  • 40:12And she very nicely compared
  • 40:13it to having a bunch of second
  • 40:16graders standing on line and the
  • 40:18types of interaction.
  • 40:19But you know that we're,
  • 40:20we're it's just hard to
  • 40:22maintain some sense of order.
  • 40:30Don't think I'll go through
  • 40:31all of you know the there's,
  • 40:34you know, they're mixed views.
  • 40:35The the predominant focus
  • 40:38was methadone's the worst.
  • 40:39And buprenorphine has some people who are
  • 40:43supportive of it is interesting to me,
  • 40:45one of the people who's a buprenorphine
  • 40:48provider who says all Suboxone is great.
  • 40:52But it's and it's it's really difficult to
  • 40:55have a sustained remission without Suboxone.
  • 40:59So I guess you could believe
  • 41:01in remission with methadone.
  • 41:03I don't like methadone at all.
  • 41:05I've yet to encounter people on
  • 41:07awake or thriving on methadone.
  • 41:10It puts the people,
  • 41:11it puts a damper on people and
  • 41:13their personalities.
  • 41:14Ohh, so there's a split which is
  • 41:17the good medication and which is
  • 41:19the bad one and then there's some
  • 41:22just very strong whatever works or.
  • 41:25And then one outreach worker who
  • 41:27I thought this is my educator you
  • 41:30know this is how Suboxone works
  • 41:31and this is how you do it.
  • 41:33And and then talking about you know,
  • 41:36even how you engage somebody,
  • 41:38you'd really be amazed at how many
  • 41:41people are interested in Suboxone.
  • 41:43Due to the fact they start realizing they
  • 41:45have grandkids that they want to be around,
  • 41:47so he's a sort of first responder
  • 41:50to overdoses in the community
  • 41:52and this we're walking,
  • 41:54that's the hardest time to
  • 41:56get somebody into treatment.
  • 41:57He engages them.
  • 41:59You have to stop using,
  • 42:01but you could stay alive and you
  • 42:03could do the things you want to do.
  • 42:06So if we think that it was just
  • 42:09our interviews that we got some
  • 42:10bias sample this last year,
  • 42:12that every quarterly there's
  • 42:13a live long DC summit,
  • 42:16about 200 people who were community leaders,
  • 42:18people who are healthcare workers,
  • 42:20anybody who's interested in opiate overdose.
  • 42:22And they are pulls it together.
  • 42:24Last year because of things we
  • 42:26were finding that, you know,
  • 42:28I gave a talk about the myths of
  • 42:30medication treatment, but before I did it,
  • 42:32we surveyed the respondents and so,
  • 42:36you know, nearly half.
  • 42:37The naltrexone is the most effective
  • 42:39treatment because it's not an opioid,
  • 42:42so can't use an opioid to treat an opioid.
  • 42:45Again,
  • 42:47about 4546% method medication treatment
  • 42:49can have long term adverse impacts on health,
  • 42:52bone deterioration,
  • 42:54teeth falling out.
  • 42:56And 40% medication treatments
  • 42:59used for short term treatment.
  • 43:02So this is generally subscribe views.
  • 43:07This is connected with this abstinence
  • 43:09only is long term residential treatments.
  • 43:13That's what worked for me and that's
  • 43:14the only thing that's going to work.
  • 43:19Keep on time. I know there's no time at all.
  • 43:24And then this is really.
  • 43:26You know the what I found part of
  • 43:29what I found so sad about this,
  • 43:31the sense the treatment is not going to
  • 43:33work for anybody that's not ready for it.
  • 43:35We've been threatened, locked up.
  • 43:36We can still continue to use
  • 43:39until an individual is ready.
  • 43:40I don't care how much you treatment
  • 43:42you put in front of them, it's always
  • 43:45on the person to be tired and fed up.
  • 43:48Community leader, Faith Leader said.
  • 43:50We don't have the tools to pay attention to
  • 43:53because there are tools that that could have,
  • 43:56we're not equipped.
  • 43:57We don't know how to deal with their pain and
  • 44:00people saying so take these as suggestions.
  • 44:03I've never seen a program or an
  • 44:05agency that will support a person that
  • 44:08has a family member that's using.
  • 44:10Oh, so so how does this, you know, play out?
  • 44:15Nothing can be done.
  • 44:16So here's a person talking about her cousin.
  • 44:18It was a known secret,
  • 44:20but people don't know how to
  • 44:22tackle the situation.
  • 44:22Well, it's not affecting me.
  • 44:25You know what,
  • 44:26nothing to do with intervening.
  • 44:29And then she said, I'm not a professional.
  • 44:31So in that sense,
  • 44:32when it's somebody familiar,
  • 44:34people don't really want to listen.
  • 44:36I find that so.
  • 44:37But like I said, it was.
  • 44:39Just like, you know, try not to look at
  • 44:42a car accident so you're driving by.
  • 44:45Even though you see, you know,
  • 44:47it's horrific, you know,
  • 44:48there's bodies on the street
  • 44:49and the cars on fire.
  • 44:51You're like, well, just be desensitized.
  • 44:53I'm just sensitized.
  • 44:54So it happens and let me go and,
  • 44:57you know, let me go about my day.
  • 44:59Some more could have been done.
  • 45:02And I'm not saying no one cared.
  • 45:03As far as mother, Father.
  • 45:05It's sad for his children.
  • 45:07He had five daughters,
  • 45:09a lot of them,
  • 45:10four of them are still in school.
  • 45:13I believe in my heart.
  • 45:14I believe that had they had support services,
  • 45:18this could have been negated.
  • 45:20Died alone in a hotel room.
  • 45:23And then that teacher.
  • 45:27Toward the end of the interview,
  • 45:29she suddenly remembered.
  • 45:30She said. And I don't know why.
  • 45:32How I forgot this pick up blocked it off.
  • 45:35It's going to start a
  • 45:36whole another conversation.
  • 45:37My neighbor across the street.
  • 45:40She was addicted to painkillers, opioids,
  • 45:42and because of it she killed her baby.
  • 45:45What happened was baby was crying,
  • 45:47probably with some persistent withdrawal,
  • 45:49and so she crushed up some of her pills
  • 45:52to give to the baby to quiet her down.
  • 45:55And I'm not sure what could have
  • 45:57been done because I didn't know
  • 45:58that was an issue for her, for her.
  • 46:00But then she said her mother knew
  • 46:03Ohh but didn't want to recognize it.
  • 46:05But she did mention something.
  • 46:07The baby was born addicted and and then
  • 46:11she remembered another overdose death.
  • 46:14Occurring right around the corner from her.
  • 46:17Ohh. I'm told my neighbor's granddaughter,
  • 46:20maybe about a month ago died
  • 46:22of a drug overdose.
  • 46:233rd House almost at the corner,
  • 46:25exactly where she was living and.
  • 46:27Who she was connected to and for
  • 46:30the most part I know if something
  • 46:32happens in a house and contrasted.
  • 46:35Without saying, but, she said.
  • 46:38You know,
  • 46:38but we've got this person with Alzheimer's.
  • 46:41Ohh, he's been lost a few times
  • 46:43and he's wandered off and.
  • 46:45So, you know, as a neighborhood now,
  • 46:47we keep an eye out for them.
  • 46:49So there's some diseases that people know
  • 46:51how to watch out for, some they don't.
  • 46:55So.
  • 46:56And there's a terrible impact
  • 46:58on family members.
  • 47:00Power.
  • 47:06So the last part of the interviews is,
  • 47:10you know, we've been trying to build on is.
  • 47:13You know that that there is some wisdom
  • 47:15who can connect and how to connect.
  • 47:17There's a lot of wisdom around that with
  • 47:20an accepting view and with persistence.
  • 47:22People saying maybe not they don't hear
  • 47:24the first time or the second time or
  • 47:26the 5th time, but at some point and
  • 47:28then they'll say, well now I'm ready.
  • 47:30So as long as you don't keep pushing
  • 47:32them away or closing yourself off.
  • 47:37And the need for people to be you know,
  • 47:41peers out there to get the support
  • 47:45or see people successful or. And or.
  • 47:53Alright, so I'll spend the last part of
  • 47:56the talk just talking about where we've
  • 47:59moved in terms of some interventions
  • 48:02that we've been piloting and that
  • 48:04I think we're about to start and.
  • 48:07A larger multi site randomized study that
  • 48:11looks like we'll get funding for or and so.
  • 48:16We need to, you know,
  • 48:17counter the misunderstanding
  • 48:19about medication treatments.
  • 48:21We need to counter the negative
  • 48:23beliefs about it out,
  • 48:25and we need to somehow be able to
  • 48:28address the stigmatizing views or.
  • 48:33And certainly need to counter the.
  • 48:36Nothing that can be done.
  • 48:38To encourage treatment.
  • 48:43So working with our Community Advisory Board,
  • 48:46they came up with, you know,
  • 48:48the community is the cure and really
  • 48:50thinking obviously this isn't going to
  • 48:52be a simple intervention, it's not good,
  • 48:54it's not like a simple single cure,
  • 48:56but there's I think of it as multi
  • 48:59pronged collaborative interventions
  • 49:01with trusted community resources,
  • 49:04credible messengers.
  • 49:06So, so we're working with as you
  • 49:09see a faith-based Community Center
  • 49:11with the peer working out of there,
  • 49:15but don't isolate or establish clearly
  • 49:17you're not going to establish a large new
  • 49:19drug treatment program in the Community,
  • 49:21work the existing resources.
  • 49:25And then out of those community centers
  • 49:27have them help work on developing
  • 49:30the anti stigma campaigns and be
  • 49:32advocates for medication treatment.
  • 49:34So to try to create equivalent of a movement,
  • 49:37people who use it educate them, ask them,
  • 49:40pay for them to create anti stigma campaigns,
  • 49:45to learn about medications,
  • 49:46to create medications can be
  • 49:49helpful campaigns to do educations,
  • 49:51train them to do it and because
  • 49:54then they become.
  • 49:55Credible messengers and spread the
  • 49:58word into their cloud networks.
  • 50:02Now we're providing,
  • 50:03we've been piloting this now
  • 50:05for the past year,
  • 50:07medication treatment on site.
  • 50:10In this fabulous DC Dream Center
  • 50:14and we do it with a peer based in
  • 50:17the Dream Center and telemedicine
  • 50:19to prescribe the buprenorphine and
  • 50:21the pier we've trained up to do
  • 50:24some interventions and counseling.
  • 50:25And part of the counseling that the
  • 50:28peer is doing is to train the patients.
  • 50:31About how medications work,
  • 50:33opiate addiction,
  • 50:34how medications work so that they can.
  • 50:37First understand it and want to use
  • 50:41it information model to be able
  • 50:43to counter some of the negative
  • 50:45attitudes that they face and say
  • 50:47why are you still on that?
  • 50:49And three,
  • 50:50potentially help educate and
  • 50:52engage people in their networks to
  • 50:55bring other people into treatment.
  • 50:58It goes back and work Stephanie
  • 51:00and I have done a long time ago on
  • 51:04AIDS outreach and interventions
  • 51:06the most effective.
  • 51:08Programs,
  • 51:08the ones that didn't use just the
  • 51:12credible messenger giving talk but
  • 51:15that engage peers in response driven
  • 51:18sampling or you know in having one
  • 51:20peer make a message and bring somebody
  • 51:23others in and creating this network
  • 51:26effect that had both the most cost
  • 51:29efficient and most effective approach.
  • 51:31So we're trying to both increase the
  • 51:34treatment and build on that approach
  • 51:36and this is a little storyboard that
  • 51:38or people have developed for what
  • 51:40we're trying to do and it it's a.
  • 51:44Basically starts off with a big
  • 51:46program or a little person versus help.
  • 51:50Is closer to closer you,
  • 51:53closer to your care in small places.
  • 51:57It's comfortable, close,
  • 51:58trusted in your community.
  • 52:02So where you live,
  • 52:05it looks like your community.
  • 52:07And then this shows this is our
  • 52:10little area and the DC Dream
  • 52:12Center where we've been providing,
  • 52:14that's miss Daphne,
  • 52:16our peer outreach worker out.
  • 52:18She's out doing some community education.
  • 52:21We've got a couple of peers and
  • 52:24health educators out in the community
  • 52:26talking about the program and engaging
  • 52:29people trying to bring them in.
  • 52:32We have power.
  • 52:34Developed their own sets of.
  • 52:37Liars and we've.
  • 52:40We've worked.
  • 52:41The district was running
  • 52:45large campaigns around Narcan.
  • 52:48Out and then they moved into
  • 52:49campaigns about treatment,
  • 52:50but all the treatments were
  • 52:53residential drug free treatments.
  • 52:55And so we started helping them
  • 52:56develop and working with the
  • 52:58communications people campaigns
  • 53:00that would talk about medications
  • 53:02and tried to help message it based
  • 53:04on what we were hearing because
  • 53:06they were starting off here.
  • 53:07Are you ready to stop and stay stopped?
  • 53:10And the answer is you're ready to
  • 53:12get help and you know you'll better.
  • 53:16So come up with I think a reasonable.
  • 53:18Campaign.
  • 53:18These will have a small effect,
  • 53:20but they'll have an effect.
  • 53:23And the idea is you can we create
  • 53:25a cumulative effect with multiple.
  • 53:28Interventions.
  • 53:31So that's our team once again.
  • 53:35Think about our own network of of people and.
  • 53:41Thank you for this opportunity
  • 53:43to be back here and talk about
  • 53:45the work we've been doing.
  • 53:47Right. And I think we've got a
  • 53:51little bit of time for questions.